#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Thyroid tumors at the limit of operability


Authors: M. Fialová 1;  D. Myšíková 1;  P. Laštůvka 2;  K. Licková 3;  J. Fiala 4;  P. Libánský 1;  S. Adámek 1;  R. Lischke 1;  V. Bobek 1
Authors‘ workplace: III. chirurgická klinika 1. lékařské fakulty Univerzity Karlovy a Fakultní nemocnice Motol 1;  Klinika otorinolaryngologie a chirurgie hlavy a krku 1. lékařské fakulty Univerzity Karlovy a Fakultní nemocnice Motol 2;  Radioterapeutická a onkologická klinika 3. lékařské fakulty Univerzity Karlovy a Fakultní nemocnice Královské Vinohrady 3;  Katedra ekonomiky, manažerství a humanitních věd, Fakulta elektrotechnická, České vysoké učení technické v Praze 4
Published in: Rozhl. Chir., 2020, roč. 99, č. 8, s. 333-342.
Category: Review
doi: https://doi.org/10.33699/PIS.2020.99.8.333–342

Overview

Comprehensive information about current thyroid carcinoma treatment options depending on its histology and extent of the disease, focusing on locally advanced findings at the limit of operability. Treatment of such a heterogeneous group requires interdisciplinary cooperation. We provide 6 unique case reports including imaging scans, description of the therapy and description of development of the condition.

Keywords:

locally advanced thyroid cancer – trachea resection


Sources
  1. Vlček P. Radiojod-refrakterní karcinom štítné žlázy a správné načasování systémové léčby. Head and Neck Cancer News 2020;3:6−11.
  2. Kopečková K. Nádory štítné žlázy − diferencované karcinomy a medulární karcinom. Head and Neck Cancer News 2020;3:4−5.
  3. Švébišová H. Léčba pacientů se zhoubnými nádory štítné žlázy. Head and Neck Cancer News 2020;3: 13−15.
  4. Jurečková A. Diferencovaný a medulární karcinom štítné žlázy. Head and Neck Cancer News 2020;3:22.
  5. Králík R. Aktuálne trendy v chirurgickej liečbe nádorov štítnej žľazy. Onkológia, Bratislava 2015;10(5):278–281.
  6. Cooper DS, Gerard M. Doherty GM, et al. Revised American Thyroid Association Management guidelines for patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19(11):1167−1214. doi:10.1089/thy.2009.0110.
  7. 7. Gimm O, Dralle H. Lymphadenektomie beim Schildrusen- and Nebenschilddrusenkarzinom. Chirurg 2007;78:182−193.
  8. Brauckhoff M, Machens A, Thanh PN, et al. Impact of extent of resection for thyroid cancer invading the aerodigestive tract on surgical morbidity, local recurrence, and cancer-specific survival. Surgery 2010;148(6):1257−1266. doi:10.1016/j.surg.2010.09.011.
  9. Smallridge R, Ain K, Asa S, et al. American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid 2012; 22(11):1104–1139. doi:10.1089/thy.2012.0302.
  10. Dvořák J. Štítná žláza, chirurgická anatomie, operační technika. 2. vyd. Serifa Praha 2002;244–252.
  11. Webový portál − Epidemiologie zhoubných nádorů v České republice http://www.svod.cz/ Report diagnózy: C73 – ZN štítné žlázy https://www.svod.cz/report.php?diag=C73&type=pdf.
  12. Kraus J, Plzák J, Kastner J. Chirurgická léčba nádorů hlavy a krku – část I. Konference 2005 VIII. setkání Klubu mladých onkologů: 19, https://www.linkos.cz/lekar-a-multidisciplinarni-tym/kongresy/po-kongresu/databaze-tuzemskych-onkologickych-konferencnich-abstrakt/chirurgicka-lecba-nadoru-hlavy-a-krku-cast-i/
  13. Glover A, Gundara J, Norlén O, et al. The pros and cons of prophylactic central neck dissection in papillary thyroid carcinoma. Gland Surg. 2013;2(4):196−205. doi:10.3978/j.issn.2227-684X.2013.10.05.
  14. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (online), 2014 URL: < http://www.nccn.org/professionals/physician_gls/pdf/thyroid.pdf>[cit. 2014-12-15].
  15. Shimaoka K, Schoenfeld D, DeWys W, et al. A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma. Cancer 1985;56:2155–160. doi:10.1002/1097-0142(19851101)56:9<2155:aid-cncr2820560903>3.0.co;2-e.
  16. De Besi P, Busnardo B, Toso S, et al. Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer. J Endocrinol Invest. 1991;14:475−480. doi:10.1007/BF03346846.
  17. Schlumberger M, Abdelmoumene A, Delisle M. Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. The Groupe d’Etude des Tumeurs a Calcitonine (GETC). Br J Cancer 1995;71:363−365. doi:10.1038/bjc.1995.73.
  18. Smallridge R, Ain K, Asa S, et al. American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid 2012;22(11):1104−1139.
  19. Haugen B, Alexander E, Bible K, et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016;26(1):1−133. doi: 10.1089/thy.2015.0020.
  20. Azrif M, Slevin N, Sykes A. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation. Radiother Oncol. 2008;89:105–113. doi:10.1016/j.radonc.2008.05.023.
  21. Bellantone R, Boscherini M, Lombardi C. Medullary thyroid carcinoma: surgical management of primary tumor and locoregional recurrence. Rays 2000;25:267–271.
  22. Kebebew E, Greenspan F, Clark O, et al. Anaplastic thyroid carcinoma: treatment outcome and prognostic factors. Cancer 2005;103:1330−1335. doi: 10.1002/cncr.20936.
  23. De Crevoisier R, Baudin E, Bachelot A, et al. Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy. Int J Radiat Oncol Biol Phys. 2004; 60:1137–1143. doi:10.1016/j.ijrobp.2004.05.032.
Labels
Surgery Orthopaedics Trauma surgery
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#